(Circulation. 1997;95:2434-2440.)
© 1997 American Heart Association, Inc.
Articles |
Evidence for a Dystrophin Missense Mutation as a Cause of X-Linked Dilated Cardiomyopathy
the Departments of Pediatrics (R.O.-L., H.L., J.S., V.G., J.A.T.) and Molecular and Human Genetics (J.A.T.), Baylor College of Medicine, Houston, Tex.
Background X-linked dilated cardiomyopathy (XLCM) has previously been shown to be due to mutations in the dystrophin gene, which is located at Xp21. Mutations in the 5' portion of the gene, including the muscle promoter, exon 1, and the exon 1–intron 1 splice site, have been reported previously. The purpose of this study was to analyze the originally described family with XLCM (and others) for dystrophin mutations.
Methods and Results Polymerase chain reaction (PCR) was used to amplify genomic DNA, and reverse-transcriptase PCR amplified cDNA from RNA obtained from heart and lymphoblastoid cell lines. Primers to the muscle promoter, brain promoter, and Purkinje cell promoter were designed, in addition to the exon 1 to exon 14 regions of dystrophin. Single-strand conformation polymorphism analysis was used for mutation detection, and DNA sequencing defined the mutation. Protein modeling was used for amino acid and secondary structure analysis. A missense mutation in exon 9 at nucleotide 1043 was identified that causes an alanine to be substituted for threonine, a highly conserved amino acid, at position 279 (T279A). This mutation results in a change in polarity in the evolutionarily conserved first hinge region (H1) of the protein and substitution of a ß-sheet for 
-helix in this portion of the protein, destabilizing the protein.
Conclusions A novel missense mutation in exon 9 of dystrophin causing an abnormality at H1 leads to the cardiospecific phenotype of XLCM.
Key Words: cardiomyopathy • genetics • dystrophin • mutation
This article has been cited by other articles:
 |
|
 |
|
  U. Philipp, C. Broschk, A. Vollmar, and O. Distl Evaluation of Tafazzin as Candidate for Dilated Cardiomyopathy in Irish Wolfhounds J. Hered., July 9, 2007; (2007) esm045v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kimura, M. Ikezawa, S. Ozasa, K. Ito, H. Ueno, K. Yoshioka, S. Ijiri, K. Nomura, K. Nakamura, M. Matuskura, et al. Novel Mutation in Splicing Donor of Dystrophin Gene First Exon in a Patient With Dilated Cardiomyopathy but No Clinical Signs of Skeletal Myopathy J Child Neurol, July 1, 2007; 22(7): 901 - 906. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Richard, E. Villard, P. Charron, and R. Isnard The Genetic Bases of Cardiomyopathies J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A79 - A89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Colan Evolving Therapeutic Strategies for Dystrophinopathies: Potential for Conflict Between Cardiac and Skeletal Needs Circulation, November 1, 2005; 112(18): 2756 - 2758. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Jefferies, B. W. Eidem, J. W. Belmont, W. J. Craigen, S. M. Ware, S. D. Fernbach, S. R. Neish, E. O. Smith, and J. A. Towbin Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy Circulation, November 1, 2005; 112(18): 2799 - 2804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Mahon, R. T. Murphy, C. A. MacRae, A. L.P. Caforio, P. M. Elliott, and W. J. McKenna Echocardiographic Evaluation in Asymptomatic Relatives of Patients with Dilated Cardiomyopathy Reveals Preclinical Disease Ann Intern Med, July 19, 2005; 143(2): 108 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Burkett and R. E. Hershberger Clinical and genetic issues in familial dilated cardiomyopathy J. Am. Coll. Cardiol., April 5, 2005; 45(7): 969 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Cohen and F Muntoni Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy Heart, August 1, 2004; 90(8): 835 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Karkkainen, T. Helio, R. Miettinen, P. Tuomainen, P. Peltola, J. Rummukainen, K. Ylitalo, M. Kaartinen, J. Kuusisto, L. Toivonen, et al. A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy Eur. Heart J., May 2, 2004; 25(10): 885 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Lapidos, R. Kakkar, and E. M. McNally The Dystrophin Glycoprotein Complex: Signaling Strength and Integrity for the Sarcolemma Circ. Res., April 30, 2004; 94(8): 1023 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Gualandi, C Trabanelli, P Rimessi, E Calzolari, L Toffolatti, T Patarnello, G Kunz, F Muntoni, and A Ferlini Multiple exon skipping and RNA circularisation contribute to the severe phenotypic expression of exon 5 dystrophin deletion J. Med. Genet., August 1, 2003; 40(8): e100 - 100. [Full Text] [PDF]
|
|
|
|
|
|
J. Feng, J. Yan, C. H. Buzin, S. S. Sommer, and J. A. Towbin Comprehensive mutation scanning of the dystrophin gene in patients with nonsyndromic X-linked dilated cardiomyopathy J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1120 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Mahon, B. P. Madden, A. L. P. Caforio, P. M. Elliott, A. J. Haven, B. E. Keogh, M. J. Davies, and W. J. McKenna Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy J. Am. Coll. Cardiol., February 6, 2002; 39(3): 455 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Mendell, C. H. Buzin, J. Feng, J. Yan, C. Serrano, D. S. Sangani, C. Wall, T. W. Prior, and S. S. Sommer Diagnosis of Duchenne dystrophy by enhanced detection of small mutations Neurology, August 28, 2001; 57(4): 645 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Su, A. Yao, I. Zubair, K. Sugishita, M. Ritter, F. Li, J. J. Hunter, K. R. Chien, and W. H. Barry Effects of deletion of muscle LIM protein on myocyte function Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2665 - H2673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Crilley, E. A. Boehm, B. Rajagopalan, A. M. Blamire, P. Styles, F. Muntoni, D. Hilton-Jones, and K. Clarke Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1953 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Arbustini, P. Morbini, A. Pilotto, A. Gavazzi, and L. Tavazzi Familial dilated cardiomyopathy: from clinical presentation to molecular genetics Eur. Heart J., November 2, 2000; 21(22): 1825 - 1832. [PDF]
|
|
|
|
|
|
G.-H. Lee, C. Badorff, and K. U. Knowlton Dissociation of Sarcoglycans and the Dystrophin Carboxyl Terminus From the Sarcolemma in Enteroviral Cardiomyopathy Circ. Res., September 15, 2000; 87(6): 489 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Arbustini, M. Diegoli, P. Morbini, B. Dal Bello, N. Banchieri, A. Pilotto, F. Magani, M. Grasso, J. Narula, A. Gavazzi, et al. Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1760 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Heling, R. Zimmermann, S. Kostin, Y. Maeno, S. Hein, B. Devaux, E. Bauer, W.-P. Klovekorn, M. Schlepper, W. Schaper, et al. Increased Expression of Cytoskeletal, Linkage, and Extracellular Proteins in Failing Human Myocardium Circ. Res., April 28, 2000; 86(8): 846 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Sussman, S. Welch, A. Walker, R. Klevitsky, T. E. Hewett, S. A. Witt, T. R. Kimball, R. Price, H. W. Lim, and J. D. Molkentin Hypertrophic defect unmasked by calcineurin expression in asymptomatic tropomodulin overexpressing transgenic mice Cardiovasc Res, April 1, 2000; 46(1): 90 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hein, S. Kostin, A. Heling, Y. Maeno, and J. Schaper The role of the cytoskeleton in heart failure Cardiovasc Res, January 14, 2000; 45(2): 273 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mestroni, C. Rocco, D. Gregori, G. Sinagra, A. Di Lenarda, S. Miocic, M. Vatta, B. Pinamonti, F. Muntoni, A. L. P. Caforio, et al. Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity J. Am. Coll. Cardiol., July 1, 1999; 34(1): 181 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Komajda, P. Charron, and F. Tesson Genetic aspects of heart failure Eur J Heart Fail, June 1, 1999; 1(2): 121 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priori, J. Barhanin, R. N. W. Hauer, W. Haverkamp, H. J. Jongsma, A. G. Kleber, W. J. McKenna, D. M. Roden, Y. Rudy, K. Schwartz, et al. Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Parts I and II Circulation, February 2, 1999; 99(4): 518 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.G. Priori, J. Barhanin, R.N.W. Hauer, W. Haverkamp, H.J. Jongsma, A.G. Kleber, W.J. McKenna, D.M. Roden, Y. Rudy, K. Schwartz, et al. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management Eur. Heart J., February 1, 1999; 20(3): 174 - 195. [PDF]
|
|
|
|
 |
|
 T. M. Olson, V. V. Michels, S. N. Thibodeau, Y. Tai, and M. T. Keating Actin Mutations in Dilated Cardiomyopathy, a Heritable Form of Heart Failure Science, May 1, 1998; 280(5364): 750 - 752. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. A. Tissenbaum and G. Ruvkun An Insulin-like Signaling Pathway Affects Both Longevity and Reproduction in Caenorhabditis elegans Genetics, February 1, 1998; 148(2): 703 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Bowles, Q. Wang, and J. A. Towbin Prospects for adenovirus-mediated gene therapy of inherited diseases of the myocardium Cardiovasc Res, September 1, 1997; 35(3): 422 - 430. [Full Text] [PDF]
|
|
|
|
|
|
A. H. Beggs Dystrophinopathy, The Expanding Phenotype: Dystrophin Abnormalities in X-Linked Dilated Cardiomyopathy Circulation, May 20, 1997; 95(10): 2344 - 2347. [Full Text]
|
|